EP 1094844 A1 20010502 - POLYNUCLEOTIDE VACCINE FORMULATIONS
Title (en)
POLYNUCLEOTIDE VACCINE FORMULATIONS
Title (de)
IMPFSTOFFFORMULIERUNGEN AUS POLYNUKLEOTIDEN
Title (fr)
FORMULATIONS DE VACCINS A BASE DE POLYNUCLEOTIDES
Publication
Application
Priority
- US 9915329 W 19990708
- US 11265598 A 19980709
Abstract (en)
[origin: WO0002591A1] The present invention relates to a novel vaccine formulation comprising nucleic acid molecules and a mineral-based adjuvant provided in a biologically effective concentration so as to improve induction of an immune response subsequent to vaccination which correlates to expression of one or more specific antigens encoded by the nucleic acid molecule.
IPC 1-7
IPC 8 full level
A61K 39/145 (2006.01); A61K 39/21 (2006.01); A61K 39/245 (2006.01); A61K 39/29 (2006.01); A61K 39/39 (2006.01); A61K 48/00 (2006.01)
CPC (source: EP)
A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61K 39/21 (2013.01); A61K 39/245 (2013.01); A61K 39/292 (2013.01); A61K 39/39 (2013.01); A61K 2039/53 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55505 (2013.01); C12N 2710/16634 (2013.01); C12N 2730/10134 (2013.01); C12N 2740/16134 (2013.01); C12N 2740/16234 (2013.01); C12N 2760/16134 (2013.01); Y02A 50/30 (2017.12)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0002591 A1 20000120; AU 4973199 A 20000201; CA 2336992 A1 20000120; EP 1094844 A1 20010502; EP 1094844 A4 20050112; JP 2002520299 A 20020709
DOCDB simple family (application)
US 9915329 W 19990708; AU 4973199 A 19990708; CA 2336992 A 19990708; EP 99933739 A 19990708; JP 2000558850 A 19990708